Lenanrt Friis-Hansen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination (NCT04842305) | Lenanrt Friis-Hansen | 2021-04-01 |
Track Lenanrt Friis-Hansen automatically
Every clearance here is in the API, with alerts when new ones post.